Cargando…
Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine
Breast cancer is the second leading cause of morbidity and mortality in women worldwide. Despite advancements in the clinical application of neoadjuvant chemotherapy (NAC), drug resistance remains a major concern hindering treatment efficacy. Thus, identifying the key genes involved in driving NAC r...
Autores principales: | Saha Detroja, Trishna, Detroja, Rajesh, Mukherjee, Sumit, Samson, Abraham O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603969/ https://www.ncbi.nlm.nih.gov/pubmed/36293493 http://dx.doi.org/10.3390/ijms232012628 |
Ejemplares similares
-
Text-Mining Approach to Identify Hub Genes of Cancer Metastasis and Potential Drug Repurposing to Target Them
por: Detroja, Trishna Saha, et al.
Publicado: (2022) -
Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2
por: Detroja, Trishna Saha, et al.
Publicado: (2022) -
The Landscape of Novel Expressed Chimeric RNAs in Rheumatoid Arthritis
por: Detroja, Rajesh, et al.
Publicado: (2022) -
The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients
por: Mukherjee, Sunanda Biswas, et al.
Publicado: (2023) -
Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets
por: Mukherjee, Sumit, et al.
Publicado: (2020)